Skip to main content
Erschienen in: AIDS and Behavior 1/2011

01.01.2011 | Original Paper

Reducing HIV-Related Risk Behaviors Among Injection Drug Users in Residential Detoxification

verfasst von: Robert E. Booth, Barbara K. Campbell, Susan K. Mikulich-Gilbertson, Carrie J. Tillotson, Dongseok Choi, James Robinson, Donald A. Calsyn, Raul N. Mandler, Lindsay M. Jenkins, Laetitia L. Thompson, Catherine L. Dempsey, Michael R. Liepman, Dennis McCarty

Erschienen in: AIDS and Behavior | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

This study of 632 drug injectors enrolled in eight residential detoxification centers within the National Drug Abuse Treatment Clinical Trials Network tested three interventions to reduce drug and sex risk behaviors. Participants were randomized to: (a) a two-session, HIV/HCV counseling and education (C&E) model added to treatment as usual (TAU), (b) a one-session, therapeutic alliance (TA) intervention conducted by outpatient counselors to facilitate treatment entry plus TAU, or (c) TAU. Significant reductions in drug and sex risk behaviors occurred for all three conditions over a 6-month follow-up period. C&E participants reported significantly greater rates of attending an HIV testing appointment, but this was not associated with better risk reduction outcomes. Reporting treatment participation within 2 months after detoxification and self-efficacy to practice safer injection behavior predicted reductions in injection risk behaviors. Findings indicate that participation in detoxification was followed by significant decreases in drug injection and risk behaviors for up to 6-months; interventions added to standard treatment offered no improvement in risk behavior outcomes.
Literatur
1.
Zurück zum Zitat National Research Council. AIDS: sexual behavior and intravenous drug use. Washington, DC: National Academy Press; 1989. National Research Council. AIDS: sexual behavior and intravenous drug use. Washington, DC: National Academy Press; 1989.
2.
Zurück zum Zitat National Research Council, Institute of Medicine. In: Normand J, Vlahov D, Moses LE, editors. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press; 1995. National Research Council, Institute of Medicine. In: Normand J, Vlahov D, Moses LE, editors. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press; 1995.
3.
Zurück zum Zitat CDC. Centers for Disease Control and Prevention: HIV/AIDS sero-surveillance report. Vol 18. Atlanta: CDC; 2008. CDC. Centers for Disease Control and Prevention: HIV/AIDS sero-surveillance report. Vol 18. Atlanta: CDC; 2008.
4.
Zurück zum Zitat Knight KR, Purcell DW, Dawson-Rose C, Halkitis PN, Gomez CA, the Seropositive Urban Injectors Study Team. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. AIDS Educ Prev. 2005;17(1 suppl A):76–88.CrossRefPubMed Knight KR, Purcell DW, Dawson-Rose C, Halkitis PN, Gomez CA, the Seropositive Urban Injectors Study Team. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. AIDS Educ Prev. 2005;17(1 suppl A):76–88.CrossRefPubMed
5.
Zurück zum Zitat Kral A, Bluthenthal R, Lorvick J, Gee L, Bacchetti P, Edlin B. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.CrossRefPubMed Kral A, Bluthenthal R, Lorvick J, Gee L, Bacchetti P, Edlin B. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.CrossRefPubMed
6.
Zurück zum Zitat Saxon AJ, Calsyn DA, Whittaker S. Freeman G. Sexual behaviors of intravenous drug users in treatment. J Acquir Immune Defic Syndr. 1991;4:938–44.PubMed Saxon AJ, Calsyn DA, Whittaker S. Freeman G. Sexual behaviors of intravenous drug users in treatment. J Acquir Immune Defic Syndr. 1991;4:938–44.PubMed
7.
Zurück zum Zitat Watkins K, Metzger D, Woody G, McLellan A. Determinants of condom use among intravenous drug users. AIDS. 1993;7:719–23.CrossRefPubMed Watkins K, Metzger D, Woody G, McLellan A. Determinants of condom use among intravenous drug users. AIDS. 1993;7:719–23.CrossRefPubMed
8.
Zurück zum Zitat Bulterys M, Chao A, Dushimimana A, et al. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS. 1993;7(12):1639–45.CrossRefPubMed Bulterys M, Chao A, Dushimimana A, et al. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS. 1993;7(12):1639–45.CrossRefPubMed
9.
Zurück zum Zitat Battjes R, Pickens R, Amsel Z, Brown L. Heterosexual transmission of human immunodeficiency virus among intravenous drug users. J Infect Dis. 1990;162:1007–11.PubMed Battjes R, Pickens R, Amsel Z, Brown L. Heterosexual transmission of human immunodeficiency virus among intravenous drug users. J Infect Dis. 1990;162:1007–11.PubMed
10.
Zurück zum Zitat Booth R, Koester S, Brewster J, Weibel W, Fritz R. Intravenous drug users and AIDS: risk behaviors. Am J Drug Alcohol Abuse. 1991;17(3):337–53.CrossRefPubMed Booth R, Koester S, Brewster J, Weibel W, Fritz R. Intravenous drug users and AIDS: risk behaviors. Am J Drug Alcohol Abuse. 1991;17(3):337–53.CrossRefPubMed
11.
Zurück zum Zitat Murphy D. Heterosexual contacts of intravenous drug abusers: implications for the next spread of the AIDS epidemic. Adv Alcohol Subst Abuse. 1987;7(2):89–97.PubMed Murphy D. Heterosexual contacts of intravenous drug abusers: implications for the next spread of the AIDS epidemic. Adv Alcohol Subst Abuse. 1987;7(2):89–97.PubMed
12.
13.
Zurück zum Zitat Garfein R, Doherty M, Monterroso E, Thomas D, Nelson K, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:S11–9.PubMed Garfein R, Doherty M, Monterroso E, Thomas D, Nelson K, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:S11–9.PubMed
14.
Zurück zum Zitat Coutinho R. HIV and hepatitis C among injecting drug users (editorial). Br Med J. 1998;317:424–5. Coutinho R. HIV and hepatitis C among injecting drug users (editorial). Br Med J. 1998;317:424–5.
15.
Zurück zum Zitat Crofts N, Caruana S, Kerger M, Bowden S. Hepatitis C on drug injecting equipment. Br Med J. 2000;321:899.CrossRef Crofts N, Caruana S, Kerger M, Bowden S. Hepatitis C on drug injecting equipment. Br Med J. 2000;321:899.CrossRef
16.
Zurück zum Zitat Bortolotti F, Stivanello A, Dall’Armi A, Rinaldi R, La Grasta F. AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers. J Acquir Immune Defic Syndr. 1988;1(4):412–3.PubMed Bortolotti F, Stivanello A, Dall’Armi A, Rinaldi R, La Grasta F. AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers. J Acquir Immune Defic Syndr. 1988;1(4):412–3.PubMed
17.
Zurück zum Zitat Power R, Hartnoll R, Daviaud E. Drug injecting, AIDS, and risk behaviour: potential for change and intervention strategies. Br J Addict. 1988;83(6):649–54.CrossRefPubMed Power R, Hartnoll R, Daviaud E. Drug injecting, AIDS, and risk behaviour: potential for change and intervention strategies. Br J Addict. 1988;83(6):649–54.CrossRefPubMed
18.
Zurück zum Zitat Booth R, Wiebel W. The effectiveness of reducing needle-related risks for HIV through indigenous outreach to injection drug users. Am J Addict. 1992;1(4):277–87. Booth R, Wiebel W. The effectiveness of reducing needle-related risks for HIV through indigenous outreach to injection drug users. Am J Addict. 1992;1(4):277–87.
19.
Zurück zum Zitat Colon H, Robles R, Freeman D, Matos T. Effects of a HIV risk reduction education program among injection drug users in Puerto Rico. Puerto Rico Health Sci J. 1993;12(1):27–34. Colon H, Robles R, Freeman D, Matos T. Effects of a HIV risk reduction education program among injection drug users in Puerto Rico. Puerto Rico Health Sci J. 1993;12(1):27–34.
20.
Zurück zum Zitat Watters J, Downing M, Case P, Lorvick J, Cheng YT, Fergusson B. AIDS prevention for intravenous drug users in the community: street-based education and risk behavior. Am J Community Psychol. 1990;18(4):587–96.CrossRefPubMed Watters J, Downing M, Case P, Lorvick J, Cheng YT, Fergusson B. AIDS prevention for intravenous drug users in the community: street-based education and risk behavior. Am J Community Psychol. 1990;18(4):587–96.CrossRefPubMed
21.
Zurück zum Zitat Calsyn DA, Saxon AJ, Freeman G. Lack of efficacy of AIDS education in reducing HIV high-risk transmission behaviors among injection drug users. Am J Public Health. 1992;82:573–5.CrossRefPubMed Calsyn DA, Saxon AJ, Freeman G. Lack of efficacy of AIDS education in reducing HIV high-risk transmission behaviors among injection drug users. Am J Public Health. 1992;82:573–5.CrossRefPubMed
22.
Zurück zum Zitat Casadonte P, Des Jarlais D, Friedman S, Rotrosen J. Psychological and behavioral impact among intravenous drug users of learning HIV test results. Int J Addict. 1990;25(4):409–26.PubMed Casadonte P, Des Jarlais D, Friedman S, Rotrosen J. Psychological and behavioral impact among intravenous drug users of learning HIV test results. Int J Addict. 1990;25(4):409–26.PubMed
23.
Zurück zum Zitat Skidmore C, Robertson J, Roberts J. Changes in HIV risk-taking behaviour in intravenous drug users: a second follow-up. Br J Addict. 1989;84:695–6.CrossRefPubMed Skidmore C, Robertson J, Roberts J. Changes in HIV risk-taking behaviour in intravenous drug users: a second follow-up. Br J Addict. 1989;84:695–6.CrossRefPubMed
24.
Zurück zum Zitat Des Jarlais D, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987–91.CrossRefPubMed Des Jarlais D, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987–91.CrossRefPubMed
25.
Zurück zum Zitat Watters J, Estilo M, Clark G. Syringe and needle exchange as HIV prevention for injection drug users. J Am Med Assoc. 1994;271:115–20.CrossRef Watters J, Estilo M, Clark G. Syringe and needle exchange as HIV prevention for injection drug users. J Am Med Assoc. 1994;271:115–20.CrossRef
26.
Zurück zum Zitat Corsi KF, Kwiatkowski CF, Booth RE. Predictors of positive outcomes for out-of-treatment opiate injectors recruited into methadone maintenance through street outreach. J Drug Issues. 2002;32(3):99–1016. Corsi KF, Kwiatkowski CF, Booth RE. Predictors of positive outcomes for out-of-treatment opiate injectors recruited into methadone maintenance through street outreach. J Drug Issues. 2002;32(3):99–1016.
27.
Zurück zum Zitat Hartgers C, van den Hoek A, Krijnen P, Coutinho RA. HIV prevalence and risk behavior among injecting drug users who participate in “low-threshold” methadone programs in Amsterdam. Am J Public Health. 1992;82(4):547–51.CrossRefPubMed Hartgers C, van den Hoek A, Krijnen P, Coutinho RA. HIV prevalence and risk behavior among injecting drug users who participate in “low-threshold” methadone programs in Amsterdam. Am J Public Health. 1992;82(4):547–51.CrossRefPubMed
28.
Zurück zum Zitat Metzger DS, Woody GE, McLellan AT, O’Brien CP, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6:1049–56.PubMed Metzger DS, Woody GE, McLellan AT, O’Brien CP, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6:1049–56.PubMed
29.
Zurück zum Zitat Moss AR, Vranizan K, Gorter R, Bacchetti P, Watters J, Osmong D. HIV seroconversion in intravenous drug users in San Francisco, 1985–1990. AIDS. 1994;8(2):223–31.CrossRefPubMed Moss AR, Vranizan K, Gorter R, Bacchetti P, Watters J, Osmong D. HIV seroconversion in intravenous drug users in San Francisco, 1985–1990. AIDS. 1994;8(2):223–31.CrossRefPubMed
30.
Zurück zum Zitat Schwartz M, Baker G, Mulvey K, Plough A. Improving publicly funded substance abuse treatment: the value of case management. Am J Public Health. 1997;87:1659–64.CrossRef Schwartz M, Baker G, Mulvey K, Plough A. Improving publicly funded substance abuse treatment: the value of case management. Am J Public Health. 1997;87:1659–64.CrossRef
31.
Zurück zum Zitat Lundgren LM, Sullivan L, Amodeo M. How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts. J Subst Abus Treat. 2006;30:121–8.CrossRef Lundgren LM, Sullivan L, Amodeo M. How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts. J Subst Abus Treat. 2006;30:121–8.CrossRef
32.
Zurück zum Zitat McCusker J, Bigelow C, Luippold R, Zorn M, Lewis BF. Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction. Am J Drug Alcohol Abuse. 1995;21(1):1–16.CrossRefPubMed McCusker J, Bigelow C, Luippold R, Zorn M, Lewis BF. Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction. Am J Drug Alcohol Abuse. 1995;21(1):1–16.CrossRefPubMed
33.
Zurück zum Zitat Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One-, three- and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse. 2001;27:19–44.CrossRefPubMed Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One-, three- and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse. 2001;27:19–44.CrossRefPubMed
34.
Zurück zum Zitat Coyle S. The NIDA HIV counseling and education intervention model: intervention manual. Atlanta: U.S. Department of Health and Human Services: GPO; 1993. Coyle S. The NIDA HIV counseling and education intervention model: intervention manual. Atlanta: U.S. Department of Health and Human Services: GPO; 1993.
35.
Zurück zum Zitat Campbell BK, Fuller BE, Lee ES, Tillotson C, Woelfel T, Jenkins L, et al. Facilitating outpatient treatment entry following detoxification for injection drug use: a multi-site test of three interventions. Psychol Addict Behav. 2009;23:260–70.CrossRefPubMed Campbell BK, Fuller BE, Lee ES, Tillotson C, Woelfel T, Jenkins L, et al. Facilitating outpatient treatment entry following detoxification for injection drug use: a multi-site test of three interventions. Psychol Addict Behav. 2009;23:260–70.CrossRefPubMed
36.
Zurück zum Zitat NIDA. Risk behavior survey. 3rd ed. Rockville: Community Research Branch, National Institute on Drug Abuse; 1993. NIDA. Risk behavior survey. 3rd ed. Rockville: Community Research Branch, National Institute on Drug Abuse; 1993.
37.
Zurück zum Zitat Dowling-Guyer S, Johnson ME, Fisher DG, Needle RH, Watters JK, Andersen MD, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1(4):383–92. Dowling-Guyer S, Johnson ME, Fisher DG, Needle RH, Watters JK, Andersen MD, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1(4):383–92.
38.
Zurück zum Zitat Weatherby NL, Needle R, Cesari C, Booth RE, McCoy CB, Watters JK, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plan. 1994;17(4):347–55.CrossRef Weatherby NL, Needle R, Cesari C, Booth RE, McCoy CB, Watters JK, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plan. 1994;17(4):347–55.CrossRef
39.
Zurück zum Zitat Sobell LC, Sobell MB. Timeline followback user’s guide: a calendar method for assessing alcohol and drug use. Toronto: Addiction Research Foundation; 1996. Sobell LC, Sobell MB. Timeline followback user’s guide: a calendar method for assessing alcohol and drug use. Toronto: Addiction Research Foundation; 1996.
40.
Zurück zum Zitat Booth RE, Lehman WE, Brewster JT, Sinitsyana L, Dvoryak S. Gender differences in sex risk behaviors among Ukraine injection users. J Acquir Immune Defic Syndr. 2007;46:112–7.PubMed Booth RE, Lehman WE, Brewster JT, Sinitsyana L, Dvoryak S. Gender differences in sex risk behaviors among Ukraine injection users. J Acquir Immune Defic Syndr. 2007;46:112–7.PubMed
41.
Zurück zum Zitat Booth RE, Kwitkowski CF, Stephens RC. Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. J Psychoactive Drugs. 1998;30(3):269–78.PubMed Booth RE, Kwitkowski CF, Stephens RC. Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. J Psychoactive Drugs. 1998;30(3):269–78.PubMed
42.
Zurück zum Zitat Stephens RC, Kwiatkowski CF, Booth RE. The effectiveness of intervention efforts on HIV risky behaviors among injection drug users and crack smokers. In: Albrecht G, Levy J, editors. Advances in medical sociology. Greenwich: JAI Press; 2000. Stephens RC, Kwiatkowski CF, Booth RE. The effectiveness of intervention efforts on HIV risky behaviors among injection drug users and crack smokers. In: Albrecht G, Levy J, editors. Advances in medical sociology. Greenwich: JAI Press; 2000.
43.
Zurück zum Zitat Fiorentine R, Nakashima J, Anglin MD. Client engagement in drug treatment. J Subst Abus Treat. 1999;17:199–206.CrossRef Fiorentine R, Nakashima J, Anglin MD. Client engagement in drug treatment. J Subst Abus Treat. 1999;17:199–206.CrossRef
44.
Zurück zum Zitat Connors GJ, Carroll KM, DiClemente CC, Longabaugh R, Donovan DM. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. J Consult Clin Psychol. 1997;65(4):588–98.CrossRefPubMed Connors GJ, Carroll KM, DiClemente CC, Longabaugh R, Donovan DM. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. J Consult Clin Psychol. 1997;65(4):588–98.CrossRefPubMed
45.
Zurück zum Zitat De Weert-Van Oene GH, Schippers GM, De Jong CA, Schrijvers GJ. Retention in substance dependence treatment: the relevance of in-treatment factors. J Subst Abus Treat. 2001;20(4):253–61.CrossRef De Weert-Van Oene GH, Schippers GM, De Jong CA, Schrijvers GJ. Retention in substance dependence treatment: the relevance of in-treatment factors. J Subst Abus Treat. 2001;20(4):253–61.CrossRef
46.
Zurück zum Zitat Marmor M, Des Jarlais DC, Cohen H, Friedman SR, Beatrice ST, Dubin N, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1(1):39–44.PubMed Marmor M, Des Jarlais DC, Cohen H, Friedman SR, Beatrice ST, Dubin N, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1(1):39–44.PubMed
47.
Zurück zum Zitat Mohl PC, Martinez D, Ticknor C, Huang M, O’Brien CP. Early dropouts from psychotherapy. J Nerv Ment Dis. 1991;179:478–81.CrossRefPubMed Mohl PC, Martinez D, Ticknor C, Huang M, O’Brien CP. Early dropouts from psychotherapy. J Nerv Ment Dis. 1991;179:478–81.CrossRefPubMed
48.
Zurück zum Zitat Luborsky L, McLellan AT, Woody GE, O’Brien CP, Auerbach A. Therapist success and its determinants. Arch Gen Psychiatry. 1985;42:602–11.PubMed Luborsky L, McLellan AT, Woody GE, O’Brien CP, Auerbach A. Therapist success and its determinants. Arch Gen Psychiatry. 1985;42:602–11.PubMed
49.
Zurück zum Zitat Bordin ES. The generalizability of the psychoanalytic concept of the working alliance. Psychother Theory Res Pract. 1979;16:252–60.CrossRef Bordin ES. The generalizability of the psychoanalytic concept of the working alliance. Psychother Theory Res Pract. 1979;16:252–60.CrossRef
50.
Zurück zum Zitat Craigie FC, Ross SM. The use of a videotape pretherapy training program to encourage treatment-seeking among alcohol detoxification patients. Behav Ther. 1980;11(2):141–7.CrossRef Craigie FC, Ross SM. The use of a videotape pretherapy training program to encourage treatment-seeking among alcohol detoxification patients. Behav Ther. 1980;11(2):141–7.CrossRef
51.
Zurück zum Zitat Stark MJ, Kane BJ. General and specific psychotherapy role induction with substance-abusing clients. Int J Addict. 1985;20(8):1135–41.PubMed Stark MJ, Kane BJ. General and specific psychotherapy role induction with substance-abusing clients. Int J Addict. 1985;20(8):1135–41.PubMed
52.
Zurück zum Zitat Verinis JS. The effect of an orientation-to-treatment group on the retention of alcoholics in outpatient treatment. Subst Use Misuse. 1996;31(10):1423–31.CrossRefPubMed Verinis JS. The effect of an orientation-to-treatment group on the retention of alcoholics in outpatient treatment. Subst Use Misuse. 1996;31(10):1423–31.CrossRefPubMed
53.
Zurück zum Zitat SAS Institute, Inc. SAS Software Version 9.1 for Windows. Cary, NC: SAS Institute, Inc; 2004. SAS Institute, Inc. SAS Software Version 9.1 for Windows. Cary, NC: SAS Institute, Inc; 2004.
54.
Zurück zum Zitat SAS Institute, Inc. SAS Software Version 9.2 for Windows. Cary, NC: SAS Institute, Inc; 2008. SAS Institute, Inc. SAS Software Version 9.2 for Windows. Cary, NC: SAS Institute, Inc; 2008.
56.
Zurück zum Zitat Jones RH. Longitudinal data with serial correlation: a state-space approach. New York: Chapman and Hall; 1993. Jones RH. Longitudinal data with serial correlation: a state-space approach. New York: Chapman and Hall; 1993.
57.
Zurück zum Zitat Koch GG, Gansky SA. Statistical considerations for multiplicity in confirmatory protocols. Drug Inf J. 1996;30:523–34. Koch GG, Gansky SA. Statistical considerations for multiplicity in confirmatory protocols. Drug Inf J. 1996;30:523–34.
58.
Zurück zum Zitat Booth RE, Corsi KF, Mikulich-Gilbertson SK. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2004;74:177–85.CrossRefPubMed Booth RE, Corsi KF, Mikulich-Gilbertson SK. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2004;74:177–85.CrossRefPubMed
59.
Zurück zum Zitat Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection users. Drug Alcohol Depend. 1996;42(1):11–20.CrossRefPubMed Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection users. Drug Alcohol Depend. 1996;42(1):11–20.CrossRefPubMed
60.
Zurück zum Zitat Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users. AIDS. 1998;12:919–29.CrossRefPubMed Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users. AIDS. 1998;12:919–29.CrossRefPubMed
61.
Zurück zum Zitat Gibson DR, Lovelle-Drache J, Young M, Hudes ES, Sorensen JL. Effectiveness of brief counseling in reducing HIV risk behavior in injecting drug users: final results of randomized trials of counseling with and without HIV testing. AIDS Behav. 1999;3(1):3–12.CrossRef Gibson DR, Lovelle-Drache J, Young M, Hudes ES, Sorensen JL. Effectiveness of brief counseling in reducing HIV risk behavior in injecting drug users: final results of randomized trials of counseling with and without HIV testing. AIDS Behav. 1999;3(1):3–12.CrossRef
62.
Zurück zum Zitat Booth RE, Lehman WE, Dvoryak JT, Brewster JT, Sinitsyna L. Interventions with injection drug users in Ukraine. Addiction. 2009;104:1864–73.CrossRefPubMed Booth RE, Lehman WE, Dvoryak JT, Brewster JT, Sinitsyna L. Interventions with injection drug users in Ukraine. Addiction. 2009;104:1864–73.CrossRefPubMed
63.
Zurück zum Zitat Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985–1997. Am J Public Health. 1999;89(9):1397–405.CrossRefPubMed Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985–1997. Am J Public Health. 1999;89(9):1397–405.CrossRefPubMed
64.
Zurück zum Zitat Prendergast ML, Urada D, Podus D. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. J Consult Clin Psychol. 2001;69:389–405.CrossRefPubMed Prendergast ML, Urada D, Podus D. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. J Consult Clin Psychol. 2001;69:389–405.CrossRefPubMed
65.
Zurück zum Zitat Semaan S, Des Jarlais DC, Sogolow E, Johnson WD, Hedges WD, Ramirez G, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002;30:S73–93.CrossRefPubMed Semaan S, Des Jarlais DC, Sogolow E, Johnson WD, Hedges WD, Ramirez G, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002;30:S73–93.CrossRefPubMed
66.
Zurück zum Zitat Sorenson J, Copeland A. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17–31.CrossRef Sorenson J, Copeland A. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17–31.CrossRef
67.
Zurück zum Zitat Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abus Treat. 2003;24(4):305–11.CrossRef Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abus Treat. 2003;24(4):305–11.CrossRef
68.
Zurück zum Zitat John D, Kwiatkowski CF, Booth RE. Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry. Drug Alcohol Depend. 2001;64(2):165–72.CrossRefPubMed John D, Kwiatkowski CF, Booth RE. Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry. Drug Alcohol Depend. 2001;64(2):165–72.CrossRefPubMed
69.
Zurück zum Zitat Sitharthan T, Kavanagh DJ. Role of self-efficacy in predicting outcomes from a programme for controlled drinking. Drug Alcohol Depend. 1990;27:87–94.CrossRef Sitharthan T, Kavanagh DJ. Role of self-efficacy in predicting outcomes from a programme for controlled drinking. Drug Alcohol Depend. 1990;27:87–94.CrossRef
70.
Zurück zum Zitat Reilly PM, Sees KL, Shopshire MS, Hall SM, Delucchi KL, Tusel DJ, et al. Self-efficacy and illicit opioid use in a 180-day methadone detoxification treatment. J Consult Clin Psychol. 1995;1:158–62. Reilly PM, Sees KL, Shopshire MS, Hall SM, Delucchi KL, Tusel DJ, et al. Self-efficacy and illicit opioid use in a 180-day methadone detoxification treatment. J Consult Clin Psychol. 1995;1:158–62.
71.
Zurück zum Zitat Kleinman BP, Millery M, Scimeca M, Polissar NL. Predicting long-term treatment utilization among addicts entering detoxification: the contribution of help-seeking models. J Drug Issues. 2002;32(1):209–30. Kleinman BP, Millery M, Scimeca M, Polissar NL. Predicting long-term treatment utilization among addicts entering detoxification: the contribution of help-seeking models. J Drug Issues. 2002;32(1):209–30.
72.
Zurück zum Zitat Bouhnik AD, Preau M, Lert F, Peretti-Watel P, Schilz MA, Obadia Y, et al. Unsafe sex in regular partnerships among heterosexual persons living with HIV: evidence from a large representative sample of individuals attending outpatient services in France. AIDS. 2007;21:S57–62.CrossRefPubMed Bouhnik AD, Preau M, Lert F, Peretti-Watel P, Schilz MA, Obadia Y, et al. Unsafe sex in regular partnerships among heterosexual persons living with HIV: evidence from a large representative sample of individuals attending outpatient services in France. AIDS. 2007;21:S57–62.CrossRefPubMed
73.
Zurück zum Zitat Gollub EL, Rey D, Obadia Y, Moatti JP. Gender differences in risk behaviors among HIV+ persons with an IDU history: the link between partner characteristics and women’s higher drug-sex risks. Sex Transm Dis. 1998;25:483–8.CrossRefPubMed Gollub EL, Rey D, Obadia Y, Moatti JP. Gender differences in risk behaviors among HIV+ persons with an IDU history: the link between partner characteristics and women’s higher drug-sex risks. Sex Transm Dis. 1998;25:483–8.CrossRefPubMed
74.
Zurück zum Zitat Lollis CM, Strothers HS, Chitwood DD, McGhee M. Sex, drugs and HIV: does methadone maintenance reduce drug use and risky sexual behavior? J Behav Sci. 2000;23:545–557. Lollis CM, Strothers HS, Chitwood DD, McGhee M. Sex, drugs and HIV: does methadone maintenance reduce drug use and risky sexual behavior? J Behav Sci. 2000;23:545–557.
75.
Zurück zum Zitat Booth RE. Gender differences in high-risk sex behaviors among heterosexual drug injectors and crack smokers. Am J Drug Alcohol Abuse. 1995;21:419–32.CrossRefPubMed Booth RE. Gender differences in high-risk sex behaviors among heterosexual drug injectors and crack smokers. Am J Drug Alcohol Abuse. 1995;21:419–32.CrossRefPubMed
76.
Zurück zum Zitat Booth RE, Koester SK, Pinto F. Gender differences in sex-risk behaviors, economic livelihood, and self-concept among drug injectors and crack smokers. Am J Addict. 1995;4:313–22. Booth RE, Koester SK, Pinto F. Gender differences in sex-risk behaviors, economic livelihood, and self-concept among drug injectors and crack smokers. Am J Addict. 1995;4:313–22.
77.
Zurück zum Zitat Des Jarlais DC, Friedman SR, Goldsmith D, Hopkins W. Heterosexual transmission of human immunodeficiency virus from intravenous drug users: Regular partnerships and prostitution. In: Voeller B, Reinisch JMR, Gottleib M, editors. AIDS and sex. New York: Oxford University Press; 1990. p. 245–56. Des Jarlais DC, Friedman SR, Goldsmith D, Hopkins W. Heterosexual transmission of human immunodeficiency virus from intravenous drug users: Regular partnerships and prostitution. In: Voeller B, Reinisch JMR, Gottleib M, editors. AIDS and sex. New York: Oxford University Press; 1990. p. 245–56.
78.
Zurück zum Zitat Maisto S, McKay J, Conners G. Self-reported issues in substance abuse: state of the art and future directions. Behav Assess. 1990;121:117–34. Maisto S, McKay J, Conners G. Self-reported issues in substance abuse: state of the art and future directions. Behav Assess. 1990;121:117–34.
Metadaten
Titel
Reducing HIV-Related Risk Behaviors Among Injection Drug Users in Residential Detoxification
verfasst von
Robert E. Booth
Barbara K. Campbell
Susan K. Mikulich-Gilbertson
Carrie J. Tillotson
Dongseok Choi
James Robinson
Donald A. Calsyn
Raul N. Mandler
Lindsay M. Jenkins
Laetitia L. Thompson
Catherine L. Dempsey
Michael R. Liepman
Dennis McCarty
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2011
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9751-7

Weitere Artikel der Ausgabe 1/2011

AIDS and Behavior 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.